These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 21901177)

  • 1. Aspirin for CV prevention -- for which patients?
    Jackson AN; Hume AL
    J Fam Pract; 2011 Sep; 60(9):518-23. PubMed ID: 21901177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspirin for diabetes: are we adhering to ADA guidelines?
    Aakash ; Sabitha P
    Natl Med J India; 2009; 22(1):49. PubMed ID: 19761164
    [No Abstract]   [Full Text] [Related]  

  • 3. Application of U.S. guidelines in other countries: aspirin for the primary prevention of cardiovascular events in Japan.
    Morimoto T; Fukui T; Lee TH; Matsui K
    Am J Med; 2004 Oct; 117(7):459-68. PubMed ID: 15464702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benefits versus risks of aspirin in cardioprotection: dangers of heart attack after discontinuation.
    Wynn RL
    Gen Dent; 2012; 60(4):255-8. PubMed ID: 22782034
    [No Abstract]   [Full Text] [Related]  

  • 5. Assessing the risk/benefit profile before recommending aspirin for the primary prevention of cardiovascular events.
    Rodondi N; Bauer DC
    Am J Med; 2004 Oct; 117(7):528-30. PubMed ID: 15464713
    [No Abstract]   [Full Text] [Related]  

  • 6. Don't use aspirin for primary prevention of cardiovascular disease.
    Barnett H; Burrill P; Iheanacho I
    BMJ; 2010 Apr; 340():c1805. PubMed ID: 20410163
    [No Abstract]   [Full Text] [Related]  

  • 7. Frequency and practice-level variation in inappropriate aspirin use for the primary prevention of cardiovascular disease: insights from the National Cardiovascular Disease Registry's Practice Innovation and Clinical Excellence registry.
    Hira RS; Kennedy K; Nambi V; Jneid H; Alam M; Basra SS; Ho PM; Deswal A; Ballantyne CM; Petersen LA; Virani SS
    J Am Coll Cardiol; 2015 Jan; 65(2):111-21. PubMed ID: 25593051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Aspirin Primary Prevention Conundrum.
    Schamroth Pravda M; Schamroth Pravda N; Beigel Y; Matetzky S; Beigel R
    Isr Med Assoc J; 2020 Jan; 22(1):60-63. PubMed ID: 31927808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspirin therapy and primary prevention of cardiovascular disease in diabetes mellitus.
    Younis N; Williams S; Soran H
    Diabetes Obes Metab; 2009 Nov; 11(11):997-1000. PubMed ID: 19531055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of guidelines on primary prevention of cardiovascular disease with aspirin: how much evidence is needed to turn a tanker?
    Matthys F; De Backer T; De Backer G; Stichele RV
    Eur J Prev Cardiol; 2014 Mar; 21(3):354-65. PubMed ID: 23610452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex-related differences in response to aspirin in cardiovascular disease: an untested hypothesis.
    Hennekens CH; Hollar D; Baigent C
    Nat Clin Pract Cardiovasc Med; 2006 Jan; 3(1):4-5. PubMed ID: 16391594
    [No Abstract]   [Full Text] [Related]  

  • 12. [Acetylsalicylic acid does not prevent cardiovascular disease. Poor scientific support for therapeutic guidelines according to primary prevention studies].
    Mooe T
    Lakartidningen; 2006 Sep 20-26; 103(38):2732-6. PubMed ID: 17058766
    [No Abstract]   [Full Text] [Related]  

  • 13. Aspirin. New uses for an old standby.
    Mayo Clin Health Lett; 2002 Dec; 20(12):7. PubMed ID: 12526110
    [No Abstract]   [Full Text] [Related]  

  • 14. Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: Recommendations From the U.S. Preventive Services Task Force.
    Ann Intern Med; 2016 Jun; 164(12):. PubMed ID: 27064765
    [No Abstract]   [Full Text] [Related]  

  • 15. Aspirin in primary prevention: sex and baseline risk matter.
    Algra A; Greving JP
    Lancet; 2009 May; 373(9678):1821-2. PubMed ID: 19482200
    [No Abstract]   [Full Text] [Related]  

  • 16. Aspirin for primary prevention of cardiovascular disease in women: does sex matter?
    Hung J
    Med J Aust; 2006 Mar; 184(6):260-1. PubMed ID: 16548826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should patients who have not had a cardiac event take ASA to prevent one?
    Alkhenizan A
    Can Fam Physician; 2002 Jan; 48():55-7. PubMed ID: 11852612
    [No Abstract]   [Full Text] [Related]  

  • 18. Aspirin, warfarin, or enoxaparin thromboprophylaxis in patients with multiple myeloma treated with thalidomide: a phase III, open-label, randomized trial.
    Palumbo A; Cavo M; Bringhen S; Zamagni E; Romano A; Patriarca F; Rossi D; Gentilini F; Crippa C; Galli M; Nozzoli C; Ria R; Marasca R; Montefusco V; Baldini L; Elice F; Callea V; Pulini S; Carella AM; Zambello R; Benevolo G; Magarotto V; Tacchetti P; Pescosta N; Cellini C; Polloni C; Evangelista A; Caravita T; Morabito F; Offidani M; Tosi P; Boccadoro M
    J Clin Oncol; 2011 Mar; 29(8):986-93. PubMed ID: 21282540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suggestions made for reducing cardiac drug errors.
    Levenson D
    Rep Med Guidel Outcomes Res; 2002 Nov; 13(23):1-2, 5. PubMed ID: 12731477
    [No Abstract]   [Full Text] [Related]  

  • 20. Antiplatelet and antithrombotic treatment of patients with peripheral arterial disease.
    Poredos P; Jezovnik MK
    Int Angiol; 2010 Feb; 29(1):20-6. PubMed ID: 20224527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.